Safety and Efficacy of Ciclesonide in Pediatric Patients (6 to 11 Years of Age) With Seasonal Allergic Rhinitis (BY9010/M1-417)

Main Inclusion Criteria:

- Written informed consent

- General good health other than seasonal allergic rhinitis

- Positive standard skin prick test

Main Exclusion Criteria:

- Pregnancy, nursing, or plans to become pregnant or donate gametes for in vitro
fertilization

- Participation in any investigational drug trial within the 30 days preceding the
Screening Visit

- A known hypersensitivity to any corticosteroid or any of the ingredients in the study
drug formulation

- Plans to travel outside the study area (the known pollen area for the investigative
site) for 24 hours or more during the final 7 days of the baseline period

- Plans to travel outside the study area (the known pollen area for the investigative
site) for more than 2 consecutive days OR more than 3 days total during the treatment
period

- Use of any prohibited concomitant medications

- Non-vaccinated exposure to or active infection with chickenpox or measles within the
21 days preceding the Screening Visit

- Use of antiepileptic drugs for epilepsy within 30 days of the Screening Visit

- Study participation by more than one patient from the same household